The prices of all registered medicines listed on the national database have increased by 2.88% from 1 October.
According to the Department of Health, the increase in the regulated single exit price (SEP) has been implemented to offer manufacturers temporary relief amid rising input costs, supply chain pressure and geopolitical factors that could affect medicine availability. All medicines registered and listed on the national database as at 30 September 2026, including all related package sizes, are affected by the increase. The department says the decision follows sustained engagement with the pharmaceutical sector and aims to balance affordability for patients and medical schemes with a sustainable supply of medicines.
The SEP is the regulated maximum price at which manufacturers and importers may sell medicines in the private sector to, among others, pharmacies, doctors who dispense medicines and hospitals. The SEP does not apply to the state.
Source: SAnews.gov.za / Department of Health
Print here to read more.
This article is an automatic English translation of a Nuusflits article originally published in Afrikaans. Read the Afrikaans original.
